REPORTED BY
NORMAN J CLEMENT RPH., DDS, NORMAN L.CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC.T. SPIRIT OF REV. C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., WALTER F. WRENN III., MD., JULIE KILLINGWORTH, LESLY POMPY MD., NANCY SEEFEDLT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., RICHARD KAUL, MD., LEROY BAYLOR, JAY K. JOSHI MD., MBA, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
FROM THE FILES OF THE DAILY REMEDY PODCAST
A conversation with Dr. Terri Lewis thought leader for opioid policy reform

There are many prominent researchers working behind the scenes to rectify erroneous opioid policies at the state and federal levels. Among these silent researchers, Dr. Terri Lewis’s work rings the loudest.
She has redefined the very meaning of data in the opioid epidemic, conducting one of the largest behavioral surveys on opioid use and the experience of chronic pain.
Through her research, we now know of inherent biases within the data used in opioid risk stratification, and the implications of these biases on the lives of chronic pain patients across the country.

TERRI LEWIS PH.D. point out”
“DEA HAS A MISSION THAT STILLS SEPARATES ITS POLICY FROM THE HEALTH OF THE POPULATION”
It is because of researchers like Dr. Terri Lewis that we understand the value of prescription opioids through the voices of people with lived experience.
To glean preliminary results from her ongoing survey, please select the link below:
Pronto Pharmacy LLC
Allegation Long Distances
14. Between September 10, 2018, and May 6, 2019, the Respondent filled:
a. 86 prescriptions for patients with addresses in Cape Coral, Florida, which is approximately 140 miles from the Respondent;
b. 145 prescriptions for patients with addresses in Fort Myers, Florida, which is approximately 130 miles from the Respondent;
c. 41 prescriptions for patients with addresses in Lehigh Acres, Florida, which is approximately 140 miles from the Respondent;
d. 15 prescriptions for patients with addresses in Immokalee, Florida, which is approximately 150 miles from the Respondent;
e. 15 prescriptions for patients with addresses in Naples, Florida, which is approximately 170 miles from the Respondent;
f. 11 prescriptions for patients with addresses in Opa-Locka, Florida, which is approximately 270 miles from the Respondent. ALJ Ex. 1, ¶¶ 15(a)–(f).
15. In addition, between September 10, 2018, and May 6, 2019, over 75 percent of the prescriptions for controlled substances filled by the Respondent were issued by prescribers whose medical practices are located more than 150 miles away from the Respondent. ALJ Ex. 1, ¶ 16.
https://drive.google.com/file/d/1lOjfEJZz8ZbebSE4O-u3rM8Ka4RD8fZI/view?usp=sharing
Pronto Pharmacy LLC
Allegation: Cash Payments
16. During the relevant time period, over 90 percent of the prescriptions for oxycodone 30 mg and hydromorphone 8 mg filled by the Respondent were paid for with cash. ALJ Ex. 1, ¶ 18. In contrast, in 2018 ‘‘approximately 11 percent of all prescriptions filled by independently owned
pharmacies . . . were paid for with cash.’’ Id.
CRIMINALIZATION OF MEDICAL CARE TREATMENT
CONGRESS MUST CLEAn up this mess
FOR NOW, YOU ARE WITHIN
THE NORMS
Thank you. I think the money available to a certain few in the DOJ/AG to control for the ‘suing’ of pharmaceutical manufacturing in ‘court’ for “fueling opioid crisis” is the prime mover in the injustice done to doctors of medicine and the abandoned, incurable, severe pain patients.